Drug Discovery Informatics Companies, Corporate Growth and Development Strategy

Explore Top Vendors in the Drug Discovery Informatics Market & Their Offering With Market Growth

Company Offerings

Value Chain Analysis

R&D

• R&D in drug discovery informatics centers on using advanced computational technologies to streamline early-stage drug research. By combining intelligent algorithms with large-scale data analysis, these solutions help shorten discovery timelines, lower development expenses, and enhance the accuracy of preclinical outcomes.
• Key players: Schrödinger, Certara, Thermo Fisher Scientific, Dassault Systèmes, and IBM.

Clinical Trials

• Clinical trials informatics supports faster drug development by using advanced software and data-driven systems to handle complex clinical research activities. These tools streamline data collection and analysis across trial phases I–III, helping reduce high failure rates often linked to poor efficacy outcomes. Platforms such as Electronic Data Capture and analytics solutions improve data quality, patient safety, and regulatory readiness.
• Key players: Oracle, Medidata (Dassault Systèmes), IQVIA, Veeva Systems, and Parexel.

Patient Support and Services

• Patient support and services within drug discovery informatics focus on using digital platforms and data-driven tools to enhance patient engagement beyond traditional therapies. By incorporating real-world data, patient insights, and advanced analytics, these solutions improve treatment adherence, personalize care pathways, and inform research decisions earlier. This patient-centric approach helps speed development while improving outcomes.
• Key players: IQVIA, Veeva Systems, Cognizant, Accenture, and PwC.

Market Growth

The global drug discovery informatics market size was estimated at USD 4.12 billion in 2025 and is predicted to increase from USD 4.6 billion in 2026 to approximately USD 12.39 billion by 2035, expanding at a CAGR of 11.64% from 2026 to 2035.

What are the Recent Developments in the Drug Discovery Informatics Market?

• In April 2025, Revvity Signals Software introduced the Signals One platform to support faster drug discovery. The solution simplifies data management across different stages of the discovery process and helps researchers handle the growing complexity of diverse drug modalities more efficiently.
• In February 2024, Aspen Biosciences introduced Pipeline, a drug discovery program management platform developed to support complex research workflows. The software is designed to efficiently handle large volumes of data, helping organizations better manage, track, and coordinate drug discovery projects.

Make smarter moves with all your Drug Discovery Informatics Market data under one roof - Access the Dashboard